If you searched for the cheapest GLP-1 provider you may have landed on TreatmentMD, which ranks telehealth companies and scores them out of ten. It is worth understanding what that site is before you act on its list. TreatmentMD is not a telehealth provider and does not say it is. It is an advertising publisher that earns a commission when you click through and sign up, and it discloses this on the page.
The short answer
TreatmentMD is a real site with real disclosures, not a scam. But it is a ranking page paid by the companies it ranks, in its own words: compensation "influences where, how and in what order listings appear." Read it as advertising, not as an independent review. And read this article the same way, because telos rx is not on their list and we have an obvious interest in that.
Check your eligibilityWhat TreatmentMD actually is
It prescribes nothing and dispenses nothing. It names no pharmacy, publishes no price of its own and has no intake form. Its own pages say "We're not a medical provider" and "We are an independent publisher and not a medical provider." That is accurate and it is stated plainly, which is more than some comparison sites manage.
Every button that looks like the start of a medical process is an outbound advertising link. The "Check Eligibility" buttons on their ranking page route through an affiliate tracking network before landing on the provider's own site. That is normal for this business model, but the buttons are styled like a clinical intake, and it is easy to click one thinking you have begun an eligibility check rather than been referred.
The disclosure, in their words
A banner at the top of the page reads: "The listings on this site are from companies from which this site receives compensation. This influences where, how and in what order listings appear on this site." Their affiliate disclosure adds that TreatmentMD "earns commissions from some telemedicine providers when visitors click through our links and sign up for their services."
Take that at face value, because it answers the only question that matters about a ranking. If payment influences the order, then position one is not a finding about quality. It is a commercial arrangement, disclosed. Nothing improper about that, and they deserve credit for saying so rather than burying it.
When a page tells you compensation influences the order of its rankings, believe it. That sentence is doing more work than the scores are.
How to read the scores
Their providers are scored to one decimal place, from 9.8 at the top down to 8.2. There are no customer reviews behind these numbers and no review counts. The methodology is described as proprietary, across five pillars with no stated weighting. A 9.8 and a 9.4 are therefore not separated by anything a reader can inspect.
Their homepage also says they list only "the top 10% of providers in each treatment category." Their methodology page does not contain that figure or any basis for it.
One detail worth a moment: the two highest-ranked brands sit above Ro, one of the largest and longest-established telehealth companies in the United States, and both run on domains registered within roughly the last year. That may be entirely fair on the merits. It is also exactly the pattern you would expect on a page where placement is influenced by payment, which is why the disclosure matters more than the decimals.
What they get right
Their compounding disclosure is better than most pages in this category, and it deserves quoting: "Compounded drugs are not FDA-approved. The FDA does not verify the safety, effectiveness, or quality of compounded drugs prior to marketing. Compounded semaglutide and compounded tirzepatide are not the same as Wegovy®, Ozempic®, Zepbound®, or Mounjaro®, and clinical trial outcomes for those branded medications do not apply to compounded versions."
That last clause is the one most sites skip. Trial results for the branded drugs do not transfer to compounded preparations, and a page earning commission on compounded products had every incentive to leave it out. They did not.
Three things to check before you click
First, the prices on a ranking page are the ranking page's summary, not a quote. Verify the figure on the provider's own site, and check whether it is an introductory rate, a prepaid annual rate or a standing monthly one. Those three things get flattened into a single number surprisingly often.
Second, treat the urgency framing as decoration. Phrases like "limited time," "lock in this pricing" and "pricing for life" appear next to several listings. If a rate is genuinely time-limited the provider will confirm it directly, and a medical decision is not one to hurry.
Third, be careful with averages. One listing states that patients lose an average of 18 percent of body weight, with no citation, positioned above the compounding disclaimer. An uncited average is not a prediction for you, and for compounded products the branded trial data does not apply, as the same site correctly explains further down the page.
A practical note as well: the ranking page advertised in their search ad, at the /glp-1/best-sites address, currently returns a 404. Their live ranking content sits elsewhere on the site.
Where telos rx fits
We are not on their list. We do not pay for placement on ranking sites, which is a choice with an obvious cost: pages like that are how a lot of people find a provider, and we are absent from them.
So compare us on the same terms you would apply to anyone on that page. Compounded semaglutide is $99 a month and compounded tirzepatide is $139, published on our product pages rather than quoted through an intermediary, with no separate membership fee. Needle-free oral GLP-1 is $269 and microdosed tirzepatide is $116, both of which most of that list does not offer at any price. Our medications are compounded and therefore not FDA-approved, and we say so on every product page for the same reason TreatmentMD does.
Check those numbers against whoever ranks first today. That is the comparison worth making, and you should make it on the providers' own sites.
Frequently asked questions
Is TreatmentMD a real telehealth provider?
No, and it does not claim to be. Its pages state "We're not a medical provider" and describe the site as an independent publisher. It ranks other telehealth companies and links out to them. No prescribing, dispensing or intake happens on the site itself.
Does TreatmentMD get paid by the companies it ranks?
Yes, and it discloses this. A banner states that listings come from companies that compensate the site and that this "influences where, how and in what order listings appear." Their affiliate disclosure confirms they earn commissions when visitors click through and sign up.
Are the TreatmentMD scores based on customer reviews?
No. The scores are assigned by the site using a methodology it describes as proprietary, across five pillars with no published weighting. There are no customer review counts or ratings behind the numbers.
Should I trust GLP-1 ranking sites at all?
They are useful for discovering names and useless as a verdict. Use one to build a shortlist, then verify every price, medication format and disclosure on each provider's own site before deciding. Where a ranking discloses paid placement, treat the order as advertising.
Why is telos rx not on their list?
Because we do not pay for placement on ranking sites. That is a commercial choice on our part and you should weigh this article accordingly. Our pricing is published openly on our own product pages so it can be compared directly against anyone on that list.
Compounded medications, including semaglutide and tirzepatide, are not FDA-approved and are not evaluated by the FDA for safety, efficacy or quality. A prescription requires review and approval by a licensed provider, approval is not guaranteed, and individual results vary. Descriptions of third-party websites reflect their publicly available content as of this article's publish date and are subject to change.